Overview

Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation

Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This study is a prospective randomized trial to compare twice daily to once daily administration of the basic immunosuppressive regimen in lung transplanted patients.
Phase:
Phase 3
Details
Lead Sponsor:
Hannover Medical School
Treatments:
Tacrolimus